title: Response to letter by Siegler and Martin-Schild regarding article, "Comparison of risk-scoring systems in predicting symptomatic intracerebral hemorrhage after intravenous thrombolysis".
authors.forename: Sheng-Feng
authors.initials: SF
authors.lastname: Sung
authors.forename: Huey-Juan
authors.initials: HJ
authors.lastname: Lin
authors.forename: Chih-Hung
authors.initials: CH
authors.lastname: Chen
mesh_terms: D002543:Cerebral Hemorrhage / Q000453:epidemiology*; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D018570:Risk Assessment / Q000379:methods*; D020521:Stroke / Q000188:drug therapy*; D015912:Thrombolytic Therapy / Q000379:methods*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator